Procurement of commercial biotechnology research supplies

PRESOLICITATION NOTICE

Subject: Procurement of commercial biotechnology research supplies

Classification code:

Product Service Code (PSC): 6640 Laboratory Equipment and Supplies

NAICS: 423450 – Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Contracting Office: NAVSUP Fleet Logistic Center Sigonella Naples, Italy 

Points of Contact: 

Ms. Maria Saggese

E-mail: maria.saggese.ln@us.navy.mil

Phone: +390815683938 

1. INTRODUCTION

The Naval Supply Systems Command (NAVSUP) Fleet Logistics Center Sigonella (FLCSI) – provides notification of its intent to award a firm-fixed-price sole-source purchase order to Change Biotec Limited.

The contract is in support to the implementation of a newly developed assay that is currently being standardized and deployed across the Defense Threat Reduction Agency (DTRA) and other Navy Research Laboratories.

2. REQUIREMENT DESCRIPTION

The requirement is for the procurement of commercial biotechnology research supplies in support of the Naval Medical Research Unit Europe, Africa, Central (NAMRU EURAFCENT). The specific requirement consists of three (3) proprietary Oxford Nanopore Technologies (ONT) sequencing kits:

One (1) MinION Mk1D pack with Rapid Sequencing Kit V14 (SQK-RAD114)

One (1) MinION Mk1D pack with Rapid Barcoding Kit 24 V14 (SQK-RBK114.24)

One (1) MinION Mk1D pack with Direct RNA Sequencing Kit (SQK-RNA004)

3. SOLE SOURCE RATIONALE

The ONT MinION Mk1D is a patented, highly specialized, proprietary commercial technology. The utilization of this exact commercial platform is required to ensure full mission capability, interoperability, and data standardization with the Defense Threat Reduction Agency (DTRA) and partner Navy research laboratories. Market research confirms that Change Biotec Limited is the sole authorized local representative and commercial pipeline for ONT equipment in the required region of performance (Africa). Sourcing through the sole authorized representative is...